Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
Schjesvold, Fredrik H, Richardson, Paul G, Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L, Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Published in Haematologica (Roma) (01.04.2021)
Published in Haematologica (Roma) (01.04.2021)
Get full text
Journal Article
Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
Schjesvold, Fredrik, Richardson, Paul G, Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L, Le-Guennec, Solenn, Campana, Frank, Van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Published in Haematologica (Roma) (01.03.2022)
Published in Haematologica (Roma) (01.03.2022)
Get full text
Journal Article
Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
Richter, Joshua, Lin, Peggy L., Garcia‐Horton, Viviana, Guyot, Patricia, Singh, Erin, Zhou, Zheng‐Yi, Sievert, Mark, Taiji, Riley
Published in Cancer medicine (Malden, MA) (01.04.2023)
Published in Cancer medicine (Malden, MA) (01.04.2023)
Get full text
Journal Article
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis
Hu, Xingdi, Wildman, Kingsley P, Basu, Subham, Lin, Peggy L, Rowntree, Clare, Saha, Vaskar
Published in Health economics review (29.12.2019)
Published in Health economics review (29.12.2019)
Get full text
Journal Article
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2− mBC Patients With Multiple Metastatic Sites
Li, Nanxin, PhD, Hao, Yanni, PhD, Xie, Jipan, MD, PhD, Lin, Peggy L., PhD, Koo, Valerie, BS, Ohashi, Erika, BA, Wu, Eric Q., PhD
Published in Clinical therapeutics (01.04.2016)
Published in Clinical therapeutics (01.04.2016)
Get full text
Journal Article
Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study
Wu, Eric Q., Koo, Valerie, Lin, Peggy L., Xie, Jipan, Hao, Yanni, Li, Nanxin, Ohashi, Erika
Published in International Journal of Breast Cancer (01.01.2015)
Published in International Journal of Breast Cancer (01.01.2015)
Get full text
Journal Article
Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer
Song, Yan, Hao, Yanni, Macalalad, Alexander R., Lin, Peggy L., Signorovitch, James E., Wu, Eric Q.
Published in Breast Cancer: Basic and Clinical Research (01.01.2015)
Published in Breast Cancer: Basic and Clinical Research (01.01.2015)
Get full text
Journal Article
Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices
Jonasch, Eric, Signorovitch, James E, Lin, Peggy L, Liu, Zhimei, Culver, Ken, Pal, Sumanta K, Scott, Jeffrey A, Vogelzang, Nicholas J
Published in Current medical research and opinion (01.10.2014)
Published in Current medical research and opinion (01.10.2014)
Get more information
Journal Article
Treatment patterns and duration in post-menopausal women with HR+/HER2- metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004-2010)
Macalalad, Alexander R, Hao, Yanni, Lin, Peggy L, Signorovitch, James E, Wu, Eric Q, Ohashi, Erika, Zhou, Zhou, Kelley, Caroline
Published in Current medical research and opinion (01.02.2015)
Published in Current medical research and opinion (01.02.2015)
Get more information
Journal Article
Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer
Li, Nanxin, Hao, Yanni, Xie, Jipan, Lin, Peggy L, Zhou, Zhou, Zhong, Yichen, Signorovitch, James E, Wu, Eric Q
Published in Current medical research and opinion (03.08.2015)
Published in Current medical research and opinion (03.08.2015)
Get more information
Journal Article
Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2- metastatic breast cancer: a retrospective chart review in community oncology practices in the US
Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L, Ohashi, Erika, Koo, Valerie, Signorovitch, James E, Wu, Eric Q, Yardley, Denise A
Published in Current medical research and opinion (01.06.2015)
Published in Current medical research and opinion (01.06.2015)
Get more information
Journal Article
Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA
Lin, Peggy L, Hao, Yanni, Xie, Jipan, Li, Nanxin, Ohashi, Erika, Koo, Valerie, Wu, Eric Q
Published in Expert opinion on pharmacotherapy (22.09.2015)
Published in Expert opinion on pharmacotherapy (22.09.2015)
Get more information
Journal Article
Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United States
Signorovitch, James E, Vogelzang, Nicholas J, Pal, Sumanta K, Lin, Peggy L, George, Daniel J, Wong, Michael K, Liu, Zhimei, Wang, Xufang, Culver, Ken, Scott, Jeffrey A, Jonasch, Eric
Published in Current medical research and opinion (01.11.2014)
Published in Current medical research and opinion (01.11.2014)
Get more information
Journal Article
Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey
Lin, Peggy L., Hao, Yanni, Xie, Jipan, Li, Nanxin, Zhong, Yichen, Zhou, Zhou, Signorovitch, James E., Wu, Eric Q.
Published in Cancer medicine (Malden, MA) (01.02.2016)
Published in Cancer medicine (Malden, MA) (01.02.2016)
Get full text
Journal Article
Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US
Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L, Ohashi, Erika, Koo, Valerie, Wu, Eric Q
Published in Experimental hematology & oncology (12.12.2015)
Published in Experimental hematology & oncology (12.12.2015)
Get full text
Journal Article
Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States
Wong, Michael K, Jonasch, Eric, Pal, Sumanta K, Signorovitch, James E, Lin, Peggy L, Wang, Xufang, Liu, Zhimei, Culver, Ken, Scott, Jeffrey A, George, Daniel J, Vogelzang, Nicholas J
Published in Expert opinion on pharmacotherapy (01.04.2015)
Published in Expert opinion on pharmacotherapy (01.04.2015)
Get more information
Journal Article
Physician experiences and preferences in the treatment of HR +/ HER 2− metastatic breast cancer in the United States: a physician survey
Lin, Peggy L., Hao, Yanni, Xie, Jipan, Li, Nanxin, Zhong, Yichen, Zhou, Zhou, Signorovitch, James E., Wu, Eric Q.
Published in Cancer medicine (Malden, MA) (01.02.2016)
Published in Cancer medicine (Malden, MA) (01.02.2016)
Get full text
Journal Article
Real-world effectiveness of everolimus-based therapy versus fulvestrant monotherapy in HR(+)/HER2(-) metastatic breast cancer
Hao, Yanni, Lin, Peggy L, Xie, Jipan, Li, Nanxin, Koo, Valerie, Ohashi, Erika, Wu, Eric Q, Rogerio, Jaqueline
Published in Journal of comparative effectiveness research (01.08.2015)
Published in Journal of comparative effectiveness research (01.08.2015)
Get full text
Journal Article
Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes of Isatuximab Plus Carfilzomib and Dexamethasone Versus Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Richter, Joshua, Lin, Peggy L, Garcia-Horton, Viviana, Guyot, Patricia, Zhou, Zheng-Yi, Sievert, Mark
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes for Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Leleu, Xavier, Delea, Thomas, Guyot, Patricia, Moynahan, Aaron, Singh, Erin, Tekle, Christina, Lin, Peggy L
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article